[Federal Register Volume 87, Number 99 (Monday, May 23, 2022)]
[Notices]
[Pages 31239-31240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-10992]
[[Page 31239]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1233; Docket No. CDC-2022-0067]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Paul Coverdell National Acute Stroke Program (PCNASP) (DP21-
2102) Evaluation. This project will collect information from funded
PCNASP recipients to gain insight into the effectiveness of
implementation approaches, including linking and using data, using
team-based approaches to coordinate stroke care, and providing
community resources in order to reach the general population and those
at highest risk of stroke events, and reduce disparities in access to
quality care for high burden populations.
DATES: CDC must receive written comments on or before July 22, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0067 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Paul Coverdell National Acute Stroke Program (PCNASP) (DP21-2102)
Evaluation (OMB Control No. 0920-1233)--Reinstatement--National Center
for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
The CDC is the primary federal agency for protecting health and
promoting quality of life through the prevention and control of
disease, injury, and disability. CDC is committed to programs that
reduce the health and economic consequences of the leading causes of
death and disability, thereby ensuring a long, productive, healthy life
for all people.
Stroke remains a leading cause of serious, long-term disability and
is the fifth leading cause of death in the United States after heart
disease, cancer, chronic lower respiratory diseases, and accidents.
Estimates indicate that approximately 795,000 people suffer a first-
ever or recurrent stroke each year with more than 146,000 deaths
annually. Although there have been significant advances in preventing
and treating stroke, the rising prevalence of heart disease, diabetes,
and obesity has increased the relative risk for stroke, especially in
African American populations. Moreover, stroke's lifetime direct cost
of health care and indirect cost of lost productivity is staggering and
imposes a substantial societal economic burden.
State programs funded through the Paul Coverdell National Acute
Stroke Program (PCNASP) are in the forefront of developing and
implementing system-change efforts to improve stroke systems of care by
using strategies like linking and using data, using team-based
approaches to coordinate stroke care, and providing community resources
to reach the general populations and specifically those at highest risk
of stroke events, and reduce disparities in access to quality care for
high burden populations.
When Congress directed the CDC to establish PCNASP in 2001, CDC
intended to monitor trends in stroke and stroke care, with the ultimate
mission of improving the quality of care for stroke patients in the
United States. Since 2021, CDC has funded and provided technical
assistance to thirteen recipients to develop comprehensive stroke
systems of care. A comprehensive system of care improves quality of
care by creating seamless transitions for individuals experiencing
stroke. In such a system, pre-hospital providers, in-hospital
providers, and early post-hospital providers coordinate patient hand-
offs and ensure continuity of care.
While PCNASP has existed since 2001, the goal and mission of the
program has evolved with each funding cycle. The 2021-2024 funding
cycle is the first such initiative to focus on addressing health equity
specifically and understanding efforts to impact stroke outcomes for
those at highest risk of stroke. CDC contracted with RTI International
to conduct a national evaluation to assess program
[[Page 31240]]
implementation as well as short term and intermediate outcomes of the
thirteen funded recipients.
CDC and RTI International propose to collect information from all
thirteen funded PCNASP recipients to gain insight into the
effectiveness of implementation approaches, including linking and using
data, using team based approaches to coordinate stroke care, and
providing community resources in order to reach the general population
and those at highest risk of stroke events, and reduce disparities in
access to quality care for high burden populations.
The information collection will focus on describing PCNASP specific
contributions to effective state-based stroke systems of care and the
costs associated with this work. Two components of the information
collection include: (1) Program implementation cost data collection
from program recipients using a cost collection tool; and (2)
interviews with key program and partner staff. Cost data collection
will focus on recipients' cumulative spending to support PCNASP
activities, spending by reporting period, and spending associated with
specific PCNASP strategies related to building comprehensive state-wide
stroke systems of care and strategies focusing on high-risk
populations. Interview questions will focus on how each recipient
implemented its strategies to increase access to and quality of
healthcare overall, as well as for patients at highest risk of stroke
events. It will identify challenges encountered and how they were
overcome, factors that facilitated implementation, lessons learned
along the way, and observed outcomes and improvements. The information
to be collected does not currently exist for large scale, statewide
programs that employ multiple combinations of strategies to build
comprehensive stroke systems of care.
The insights to be gained from this data collection will be
critical to improving immediate efforts and achieving the goals of
spreading and replicating state-level strategies that are proven
programmatically and are cost-effective in contributing to a higher
quality of care for stroke patients. OMB approval is requested for
three years. CDC requests OMB approval for an estimated 104 annual
burden hours. Participation is voluntary and there are no costs to
respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Program Manager............... Cost Collection 13 1 2 26
Tool.
Program Director.............. Interview....... 13 1 1 13
Quality Improvement Specialist Interview....... 13 1 1 13
Partner Support Staff......... Interview....... 52 1 1 52
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 104
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-10992 Filed 5-20-22; 8:45 am]
BILLING CODE 4163-18-P